Clinical Trials Directory

Trials / Completed

CompletedNCT00064935

Endometrial Biopsy in Infertile Patients

Utility of the Endometrial Biopsy in the Evaluation of the Luteal Phase

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
880 (planned)
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · NIH
Sex
Female
Age
25 Years – 39 Years
Healthy volunteers
Accepted

Summary

When a woman becomes pregnant, the fertilized egg attaches itself to the lining of the uterus (endometrium). The endometrium is constantly changing throughout a woman's menstrual cycle in response to the female hormones estrogen and progesterone. The endometrium must have certain characteristics (be at a specific phase in its cycle) in order for the fertilized egg to successfully attach. Infertility may be caused by an "out of phase" endometrium (i.e., the endometrium doesn't have the right characteristics when the fertilized egg reaches it). The purpose of this study is to evaluate whether the endometrial biopsy is useful in predicting the potential for becoming pregnant and bearing a child.

Detailed description

This study will evaluate the utility of the endometrial biopsy as a tool for the routine evaluation of the luteal phase of women presenting for infertility evaluation. The study will establish whether the mid-luteal or late-luteal phase is the most appropriate time to perform an endometrial biopsy. The study will be conducted through the multi-center Reproductive Medicine Network. Women with a history of infertility will be age matched to fertile women (controls). Women will be randomized either to the mid-luteal phase (7 to 8 days post-ovulation) endometrial biopsy group or to the late-luteal phase (12 to 13 days post-ovulation) endometrial biopsy group. Endometrial specimens will be evaluated histologically by a "blinded" pathologist.

Conditions

Interventions

TypeNameDescription
PROCEDUREEndometrial biopsy

Timeline

Start date
1999-04-01
Completion
2002-02-01
First posted
2003-07-16
Last updated
2005-06-24

Locations

8 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00064935. Inclusion in this directory is not an endorsement.